Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody
response in infected patients remains largely unknown, and the clinical value of antibody …

Background & Aims Hepatitis B virus (HBV) RNA in serum has recently been linked to
efficacy and prognosis of chronic hepatitis B (CHB) treatment. This study explored the nature, …

Background All currently available SARS-CoV-2 vaccines are administered by
intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated …

Dear Editor, Since the beginning of this century, humanity has been struck three times by the
coronavirus outbreak. The most recent one is caused by the SARS-CoV-2 virus, which was …

Remarkable progress has been made in developing intramuscular vaccines against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, they are limited with …

The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants
and “anatomical escape” characteristics threaten the effectiveness of current coronavirus …

Multiple safe and effective vaccines that elicit immune responses against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) are necessary to respond to the ongoing …

Astrocytes are the largest group of glial cells in the brain and participate in several essential
functions of the central nervous system (CNS). Disruption of their normal physiological …

The emergence of numerous variants of SARS-CoV-2, the causative agent of COVID-19,
has presented new challenges to the global efforts to control the COVID-19 pandemic. Here, …

Epidemiological studies of the COVID-19 patients have suggested the male bias in outcomes
of lung illness. To experimentally demonstrate the epidemiological results, we performed …